Pyruvate oxidase of Streptococcus pneumoniae contributes to pneumolysin release
BMC Microbiology volume 16, Article number: 271 (2016)
Streptococcus pneumoniae is one of the leading causes of community acquired pneumonia and acute otitis media. Certain aspects of S. pneumoniae’s virulence are dependent upon expression and release of the protein toxin pneumolysin (PLY) and upon the activity of the peroxide-producing enzyme, pyruvate oxidase (SpxB). We investigated the possible synergy of these two proteins and identified that release of PLY is enhanced by expression of SpxB prior to stationary phase growth.
Mutants lacking the spxB gene were defective in PLY release and complementation of spxB restored PLY release. This was demonstrated by cytotoxic effects of sterile filtered supernatants upon epithelial cells and red blood cells. Additionally, peroxide production appeared to contribute to the mechanism of PLY release since a significant correlation was found between peroxide production and PLY release among a panel of clinical isolates. Exogenous addition of H2O2 failed to induce PLY release and catalase supplementation prevented PLY release in some strains, indicating peroxide may exert its effect intracellularly or in a strain-dependent manner. SpxB expression did not trigger bacterial cell death or LytA-dependent autolysis, but did predispose cells to deoxycholate lysis.
Here we demonstrate a novel link between spxB expression and PLY release. These findings link liberation of PLY toxin to oxygen availability and pneumococcal metabolism.
S. pneumoniae (pneumococcus) is a Gram-positive human pathogen identified as a cause of acute otitis media, bacteremia, septicemia, pneumonia, and meningitis  and is the leading cause of death in children under the age of five worldwide . Diseases resulting from pneumococcal infection impart a major economic impact, with healthcare costs estimated to range from 3 billion to 6 billion dollars annually in the United States for otitis alone . In spite of this major disease burden, it most often exists as a commensal organism of the nasopharynx, with carriage rates of up to 70 % depending on the demographic . Pneumococcus produces and secretes a number of surface proteins which contribute to virulence including neuraminidase, hyaluronidase, and pneumococcal surface protein A (PspA) [5–7]. However, it produces relatively few protein exotoxins compared to other pathogenic species capable of such invasive disease.
The primary toxin expressed by S. pneumoniae is pneumolysin (PLY), which is a 53-kDa cholesterol dependent pore-forming cytolysin (CDC) . PLY has been found to reduce ciliary beating within the lungs and deletion of the ply gene from the pneumococcal chromosome attenuates virulence in vivo . Additionally, exposure to PLY activates differential gene expression within host cells . Unlike the other members of the CDC family, PLY lacks an N-terminal signal sequence for extracellular release via the Sec-dependent pathway . Despite this, it is well established that PLY is released into the extracellular space [8, 9, 12].
Controversy exists as to the primary route PLY takes to exit the cytoplasm. The mechanism of release was long thought to be solely attributable to autolysis of the bacterial cell . However, PLY release has been demonstrated in the absence of autolysis , suggesting that other mechanisms must contribute to liberation of PLY during pneumococcal growth. Other findings have demonstrated that PLY can actually traverse and associate with the pneumococcal cell wall . Subsequent studies by Price et al. demonstrated that domain 2 of PLY is essential for the cell wall association and that the export pathway was conserved in Bacillus subtilis . The composition of the pneumococcal peptidoglycan has been recently shown to restrict PLY release . Interestingly, this study found that greater PLY release does not correlate with enhanced virulence and that rather a controlled release of PLY is important for pathogenesis. These findings underline the fact that, while capable of inflicting damage to the host, PLY is also a stimulator of host immune responses .
S. pneumoniae is unique among catalase-negative organisms due to the fact that it produces up to millimolar concentrations of hydrogen peroxide (H2O2), primarily through the activity of the enzyme pyruvate oxidase (SpxB) [18, 19]. In aerobic environments, pneumococcus utilizes SpxB to convert pyruvate to acetate, a reaction that produces acetyl phosphate, CO2, and H2O2 . Although SpxB-derived H2O2 is detrimental to survival of the pneumococcus at high concentrations, deletion of spxB has been shown to reduce virulence in vivo . Pneumococcal H2O2 has also been shown to aid the pneumococcus in competing with other inhabitants of the upper respiratory tract  and possibly has a significant impact upon host cells and tissues. It is cytotoxic to numerous cell types including neuronal cells, neutrophils, and alveolar epithelial cells [23–26]. During stationary phase, pneumococcal H2O2 results in pneumococcal cell death resembling apoptosis of eukaryotic cells and this process does not require the major autolysin, N-acetylmuramoyl-l-alanine amidase (LytA) . However, strains vary in their production of H2O2, with some strains producing significant concentrations prior to stationary phase. The impact of low and intermediate levels of H2O2 upon the physiology and structural integrity of S. pneumoniae has not been investigated in detail. Price et al. demonstrated PLY associating with the cell wall , indicating that by some mechanism PLY escapes the cell membrane. Additionally, pneumococcus is known to alter its membrane composition in response to endogenous reactive oxygen species  Based on these results, we hypothesized that pneumococcal H2O2 might have non-lethal effects on the physiology of the bacterium at early phases of growth, possibly affecting release of PLY. We investigated the impact of SpxB on PLY localization into bacterial supernatants and the effect of this upon host cell integrity.
Bacterial strains and culture conditions
S. pneumoniae strains TIGR4 , an unencapsulated mutant of TIGR4 (T4R) , WU2 , AW267, along with isogenic mutants of these strains were grown in Todd Hewitt media plus 0.5 % yeast extract (THY) to a mid-logarithmic phase of growth (OD600 of 0.5) at 37 °C. Clinical isolates were received from the Center for Disease Control and Prevention’s Active Bacterial Core surveillance (ABCs) isolate bank (http://www.cdc.gov/abcs/index.html). For additional studies strains lacking the major cell wall amidase LytA (ΔlytA) were created as described below. The ∆lytA isogenic mutants of T4R and WU2, along with ∆lytA∆spxB double mutants were cultured under the same conditions as parental strains. To neutralize pneumococcal H2O2 from supernatants, THY media was supplemented with catalase derived from Aspergillus niger (2 ng/mL; cat #C3515 Sigma Aldrich). A549 type 2 lung epithelial cells (ATCC) were cultured in F12-K medium (ATCC) supplemented with 10 % fetal bovine serum (FBS) at 37 °C in 5 % CO2 atmosphere.
Isogenic ∆spxB mutants were developed in the strains TIGR4, WU2, T4R, and AW267 by allelic replacement. Briefly, the spxB gene with 500 base pairs flanking each end was amplified from T4R chromosomal DNA using primers ALR1 and ALR2, designed to contain both KpnI and XbaI restriction sites. The product was digested with KpnI and XbaI restriction endonucleases (New England BioLabs, Ipswich, MA) and ligated into KpnI and XbaI digested pBluescript vector using T4 DNA ligase (Thermo Fisher Scientific). Inverse PCR was performed using primers ALR3 and ALR4 to amplify outward from just inside the coding sequence of spxB from a positive clone. Primers ALR3 and ALR4 were designed to include BamHI sites. The gene ermB was amplified using designed primers ALR5 and ALR6 including BamHI sites and both products were digested with BamHI (New England BioLabs, Ipswich, MA) overnight at 37 °C. The linearized vector that was amplified with primers ALR3 and ALR4 and the ermB insert amplified with primers ALR5 and ALR6 were ligated and transformed into DH5α E. coli cells. Positive colonies with bands of the appropriate size were grown in LB medium overnight and frozen at −80 °C. PCR products containing the knockout construct were amplified from positive clones and used to transform pneumococcal strains by standard methods and subsequent selection for transformants by plating on blood agar plates containing erythromycin (0.5 μg/mL). Mutants lacking the lytA gene were generated in strains T4R and WU2 by overlap extension PCR mutagenesis as previously described . Briefly, 500–1000 base pair DNA sequences flanking each side of the lytA gene were amplified using primers LytA-KO1, LytASup LytASdn, and LytA-KO4 (Table 1) and fused by PCR to the spectinomycin resistance cassette amplified from the shuttle vector pNE-1. The lytA gene was replaced with a spectinomycin cassette following transformation of S. pneumoniae strains by standard methods and selected for by plating on blood agar plates supplemented with spectinomycin (500 μg/mL). The T4R ∆ply mutant was created using the same method (with primers PlyAF, PlyAR, PlyBF, PlyBR), but replacing the ply gene with an erythromycin cassette. Primer sequences for all mutants are listed in Table 1. Complemented mutants in strains TIGR4 and T4R were developed through cloning the spxB gene from T4R by amplifying the gene by PCR with primers SpxB-F and SpxB-R followed by digestion of the product with EcoRI and XmaI enzymes (New England Biolabs, Ipswich, MA). Following digestion of the product, the gene was ligated with the pNE-1 pneumococcal shuttle vector that was similarly digested. The ligation was transformed into E. coli strain DH5α. Purified plasmid was then used to transform ∆spxB strains by standard methods and complemented mutants were selected by plating on blood agar plates supplemented with erythromycin (0.5 μg/mL) and spectinomycin (500 μg/mL). Complementation of spxB was confirmed by PCR and by assaying supernatant from clones by a Pierce Quantitative Peroxide Assay (cat# 23280; Life Technologies).
Pneumococci were grown to mid-log phase (OD600 of 0.5). Following centrifugation (16,000 × g for 5 min) of 1 mL of the culture, the supernatant was subsequently filtered through a 0.22 μm polyethersulfone (PES) membrane syringe filter (CellTreat) to remove remaining bacterial cells and analyzed for hydrogen peroxide production using a colorimetric hydrogen peroxide quantification assay per manufacturer instructions in a BioTek Synergy HT plate reader at an OD540 (cat# 23280; Life Technologies). This analysis was performed in triplicate.
To ascertain the impact of H2O2 alone on the release of PLY, T4R and its isogenic ΔspxB mutant were grown to mid log phase (OD600 of 0.5) in 5 mL of THY media and treated with either 0 μM or 500 μM H2O2. Samples were then placed on ice for 1 h, after which H2O2 was quantified following centrifugation of 1 mL of culture at 15,000 rpm for 5 min and filtration of the supernatant through PES (CellTreat) syringe filters as described above. Bacterial counts were determined before and after the H2O2 treatment by viable plate counts using blood agar plates.
To determine the relative amount of PLY released between parental and mutant strains, sterile-filtered bacterial supernatants from cultures grown to mid-log phase (OD600 of 0.5) were denatured by boiling for 5 min and separated on 10 % SDS-PAGE gels (Bio-Rad) prior to being transferred onto a 0.22 nm PVDF membrane (Millipore). The membranes were then blocked for 30 min (5 % milk) and probed with rabbit polyclonal anti-PLY antibody overnight. The blot was subsequently washed with and probed with goat anti-rabbit HRP conjugated secondary antibody (BioRad) for 1 h. Blots were incubated with Luminata Forte substrate (Millipore) for 1 min at 25 °C. The membranes were then developed following exposure to radiography film (GeneMate). Band density was calculated using ImageJ software after scanning film at 600 dpi (NCBI).
To quantitate PLY in the supernatants, recombinant PLY was serially diluted into THY media to create a standard of known concentration (20 ng to 5 μg). PLY standards (20 μL) and bacterial supernatants (100 μL) were applied onto PVDF membranes using a dot blotting vacuum manifold (Bio-Rad). Following 45 min of gravity filtration, light vacuum was applied to adhere the protein to the membrane and the wells were washed twice using 200 μL of phosphate buffered saline (PBS). The membrane was then blocked for 30 min in 5 % milk. The membrane was then probed with an anti-PLY rabbit polyclonal antibody at a 1:200 dilution overnight. Following exposure to the primary antibody, the blot was then probed with a goat anti-rabbit secondary for 1 h. The blot was developed using Luminata Forte substrate (Millipore) and exposed to X-ray film (GeneMate). Dot density was quantitated using ImageJ (NCBI) and then plotted against the known concentration of standards to determine quantity of PLY per 100 μL.
Real time PCR
Pneumolysin gene expression in T4R, WU2, AW267, and their respective isogenic ∆spxB mutants was quantitated by qRT-PCR. Bacterial strains were grown to an OD600 of 0.5 in THY. Bacterial RNA was extracted following sonication of the bacterial culture, and a total of 4 min of bead beating with 0.1 mm zircon beads. Bacterial RNA was purified using the Qiagen RNeasy kit, with the inclusion of an on column RNase-free DNase treatment for 1 h. Bacterial RNA was quantitated using a Qubit fluorometer and 50 ng was used to generate cDNA utilizing a Maxima cDNA synthesis kit for qRT-PCR (Life Technologies). Gene-specific primer sequences PLY-F and PLY-R are listed in Table 1. The fold-change in gene expression was calculated using the ∆∆CT method utilizing gyrA as an internal control.
To assess the effect of bacterial supernatants upon human cells, 1 × 105 A549 epithelial cells were treated with filtered bacterial supernatant obtained from T4R, T4R∆spxB, T4R∆ply, and the complemented T4R∆spxB (∆spxB+). Briefly, epithelial cells were pelleted by centrifugation at 380xg for 4 min, suspended in 0.2 mL of filtered bacterial supernatant, and incubated at 37 °C for 30 min on a rotating platform. Cells were then pelleted at 380 × g for 4 min and suspended in 0.5 mL PBS with 3 μg/mL propidium iodide (PI) (Sigma Aldrich). The cells were assessed using an Attune Flow Cytometer (Life Technologies) and the fluorescence intensity shift in the BL3 channel was measured as an indicator of epithelial cell death.
PLY release was quantitated by standard hemolytic assay. Briefly, bacterial supernatants from cultures grown to an OD600 of 0.3 were serially diluted (1:3) across the microtiter plate into phosphate-buffered saline (PBS) containing 0.1 % dithiothreitol (Sigma, St. Louis, MO). Washed 1 % sheep red blood cells in PBS were added to the wells and incubated at 37 °C for 30 min. After incubation, the sheep erythrocytes were pelleted and plates were imaged.
Extracellular DNA quantitation
Bacterial strains were grown in THY medium to an OD600 of 0.5 and extracellular DNA was quantitated from sterile filtered supernatant by a Qubit fluorometer using Qubit dsDNA HS Assay Kit (Thermo Fisher Scientific).
S. pneumoniae T4R and the isogenic ∆spxB mutant were grown in 12 mL of THY at 37 °C. Upon reaching OD600 0.45, each 12 mL culture was split into three separate tubes. The separate tubes containing mid-log phase bacteria were incubated at room temperature until reaching an OD600 of 0.5. Upon reaching the desired OD, Triton X-100 (0.5 %) or sodium deoxycholate (0.05 %) was added to the respective culture tubes and the OD600 of the cultures was recorded every minute for a total of 10 min for each of the three culture tubes. Controls received no detergents. Additional control and experimental samples were grown in the presence of catalase (2 μg/mL).
Statistical analysis. All statistical analyses (Student’s t-test (two-tailed) and linear best-fit regression) were performed using GraphPad Prism software (www.graphpad.com) with a p-value < 0.5 considered significant.
Expression of SpxB enhances PLY-dependent cell death
To determine the relative contribution of H2O2 and PLY secreted by pneumococcus to cytolysis of airway epithelial cells, A549 human lung epithelial cells were exposed to filter-sterilized supernatants collected from mid-log phase cultures of S. pneumoniae and isogenic mutants lacking either spxB or ply genes and the loss of membrane integrity was assessed by uptake of PI. Compared to THY media alone, exposure to supernatant from the parental strain T4R led to a nearly complete loss of A549 cell viability (89 %), while exposure to supernatant from a strain lacking pyruvate oxidase (T4R∆spxB) resulted in minimal loss in membrane integrity (1.65 %; Fig. 1a). This effect was shown to be dependent upon release of PLY into the supernatant since supernatant from a strain containing a functional spxB gene but lacking the ply gene (T4R∆ply) resulted in only 2.52 % of cells staining PI positive. Complementation of spxB (TR4∆spxB+) restored the percentage of dead cells to nearly that of A549 cells treated with T4R supernatant (70 % vs. 89 %, respectively). Similar results were obtained using a standard hemolysis assay, with supernatant from strains expressing PLY and SpxB leading to greater hemolysis than T4R∆spxB (Fig. 1b) Strains lacking both SpxB and PLY had no hemolysis, comparable to T4R∆ply (data not shown). These data demonstrate that expression of SpxB contributes to PLY-dependent cytotoxicity at mid-log phase growth.
SpxB is responsible for the production of H2O2 among S. pneumoniae isolates at mid-log phase
S. pneumoniae is known to produce up to millimolar concentrations of H2O2 during growth . The enzyme pyruvate oxidase (SpxB) is known to be responsible for the majority of peroxide production by pneumococcus grown aerobically . However, the enzyme lactate oxidase is also capable of producing H2O2 . We assessed the relative production of H2O2 among a panel of laboratory strains. Pneumococcal strains T4, T4R, WU2, and AW267 and their isogenic ∆spxB mutants were grown to mid-log phase (OD600 of 0.5) in THY and H2O2 was quantitated from filtered supernatants (Additional file 1: Figure S1 A-D). Peroxide concentrations were found to vary between strains. However, the deletion of spxB in all strains examined resulted in a significant reduction of H2O2 (P < 0.005), which was comparable to supernatants from cultures grown in the presence of catalase. These results demonstrated that SpxB is primarily responsible for the production of the H2O2 by the strains examined in this study during mid-log phase growth.
SpxB enhances PLY release among S. pneumoniae isolates
To determine the contribution of SpxB upon PLY release, supernatants from TIGR4, T4R, WU2, and AW267, and their isogenic ∆spxB mutants, grown to OD600 of 0.5, were analyzed by SDS-PAGE and western blot. A significant reduction in the amount of PLY released into the supernatants was observed in the ∆spxB mutant of each strain examined (Fig. 2 a-d). Differences in PLY release between wild-type and ∆spxB strains were not due to differences in colony forming units in the mid-log cultures as determined by plate counts (Additional file 2: Figure S2). Interestingly, addition of catalase to the medium only attenuated PLY release in high-releasing strains AW267 and WU2. Since catalase cannot cross the cell membrane and therefore can only neutralize extracellular H2O2, it is possible that the strains have different sensitivity to endogenous versus exogenous H2O2. Complementation of spxB restored the ability of strains to release significant concentrations of PLY (Fig. 2 e and f).
To determine if PLY release correlated with H2O2 production in additional strains, a panel of 15 clinical isolates was analyzed. Each strain was grown to mid-log phase (OD600 of 0.5), serial dilutions of the culture were plated, and supernatants were used for and PLY and H2O2 quantitation. A dot blot assay was used to quantitate PLY as plotted against known concentrations of recombinant PLY. PLY and H2O2 concentrations were normalized to 100,000 cells and a linear scatter plot was generated (Fig. 3). A significant correlation was observed between H2O2 production and PLY released among the isolates examined (r 2 = 0.3167; p < 0.05). This suggests that H2O2 production impacts PLY release in clinically-relevant strains.
Effects of SpxB on ply gene expression
It is possible that expression of SpxB affects ply gene expression by metabolically altering the intracellular environment. To determine if deletion of spxB has a deleterious effect on ply gene transcription, leading to reduced amounts of PLY in the supernatant, qRT-PCR was performed on RNA isolated from strains grown to mid-log phase (Fig. 4). Surprisingly, the transcription of ply was found to be increased in all ΔspxB mutants analyzed (AW267∆spxB: 2.83-fold, WU2∆spxB: 1.96-fold, T4R∆spxB: 2.3-fold) which was in contrast to PLY release results shown in Fig. 2. Therefore, the reduced PLY release seen in ΔspxB mutants is not due to reduced transcription of the ply gene.
Impact of exogenous H2O2 on PLY release
H2O2 is a by-product of SpxB activity and is known to have physiological effects upon pneumococcus. To determine the extent to which exogenous H2O2 can impact the release of PLY by inducing bactericidal lysis, T4R∆spxB was treated with either 0 μM or 500 μM H2O2 on ice for 1 h and the concentration of PLY in the supernatant was determined via dot blot. Interestingly, no significant difference was found between the H2O2-treated bacteria and those not receiving H2O2 (Fig. 5a). To ensure exposure to H2O2 did not impact bacterial survival, and therefore PLY production, bacterial colony forming units were enumerated prior to and after H2O2 exposure. Concentrations up to 500 μM did not impact bacterial survival (Additional file 3: Figure S3). Additionally, no significant difference in DNA release was seen with strains lacking spxB (Fig. 5b). These results, combined with the lack of catalase protection in the T4R strain (Fig. 2d), indicate that the contribution of SpxB to PLY release is not due to exogenous effects of H2O2 on bacterial viability and that H2O2 may exert its effects endogenously as it is being made.
SpxB-dependent PLY release is not due to autolysis
Another potential explanation for the difference in PLY release between the ΔspxB mutant and the parental strain is that loss of spxB leads to decreased autolysis even prior to stationary phase. Assays for autolysis were performed to determine if this was a contributing factor. Autolysis of S. pneumoniae involves the activity of the cell wall amidase LytA . To determine whether LytA affected SpxB-dependent PLY release, western blots were performed on mid-log (OD600 of 0.5) supernatants from parental strains T4R and WU2 as well as isogenic mutants of both strains lacking either lytA or spxB, or both (Fig. 6a). Mutants lacking spxB, as expected, released less PLY, however loss of lytA had no significant effect on PLY release. These results indicate that the major autolysin, LytA, is not contributing to SpxB-induced PLY release at mid-log phase growth, but does not rule out its contribution at later times, such as during stationary phase.
It is possible that H2O2 or another by-product of SpxB activity could weaken the bacterial cell membrane, thereby facilitating PLY release. To determine if SpxB expression affected detergent-induced lysis, T4R and its isogenic ∆spxB mutant were grown to an OD600 of 0.5 and then treated with the ionic detergent sodium deoxycholate (DOC). As expected, addition of DOC to mid-log phase cultures initiated immediate lysis of both T4R and ∆spxB strains. However, wild type T4R lysed more rapidly and to a greater extent than T4R∆spxB. Supplementing the medium with catalase reduced lysis to levels comparable to T4R∆spxB, indicating that H2O2 production may induce a condition that favors progression of lysis.
Pneumolysin is a major virulence factor of pneumococcus and its release into the extracellular space has been shown to vary greatly between strains [9, 35]. However, no single canonical mechanism of PLY release has been identified . In this work, we have identified a novel link between expression of the metabolic enzyme pyruvate oxidase and release of PLY. Initially, we sought to determine the relative contribution of secreted H2O2 and PLY to host epithelial cytotoxicity. However, upon exposing A549 epithelial cells to pneumococcal supernatants, we found that supernatants from strains lacking SpxB showed significantly decreased cytotoxicity, due to reduced extracellular PLY release. Since H2O2 has been shown to be the primary cause of pneumococcal autolysis during stationary phase , we initially suspected the loss of viability by H2O2 produced by SpxB might cause the enhanced release of PLY in culture supernatant. However, there was no significant difference in colony forming units between parental and spxB mutants. Additionally, there was no significant difference in extracellular DNA concentrations between parental and ∆spxB mutants. Together, these results suggest that enhanced release of PLY in parental strains during mid-log phase growth was not due to a bactericidal effect of H2O2 produced by SpxB. While pneumococcal H2O2 is known to have cytotoxic effects on host cells [24, 26], our results indicate that the loss of host cell integrity is primarily linked to PLY released into the supernatant, not to H2O2. However, it is possible that SpxB-dependent H2O2 induces stress within epithelial cells that may lead to alternative, non-cytolytic death processes. For instance, it has been shown that SpxB-induced H2O2 triggers genotoxicity and conserved stress responses within the epithelium [24, 36].
While H2O2-induced bactericidal effects do not appear to be the mechanism for PLY release, our findings do indicate that release may be linked to the production of H2O2, as indicated by the correlation between PLY release and H2O2 production in our clinical isolate panel. However, SpxB enzymatic activity produces other byproducts, including acetate and acetylphosphate that could potentially contribute to this mechanism of release . Acetyl-phopshate contributes significantly to the ATP pool of pneumococcus . We are currently investigating whether PLY release is energy-dependent. Furthermore, the addition of catalase to the culture medium abrogated PLY release from some strains (WU2), while failing to prevent release from others (TIGR4). These results suggest that strain-specific differences in metabolism might impact the release of PLY. We are also currently investigating how the capsule genes possessed by different serotypes may alter their metabolic processes and thereby SpxB activity and subsequent PLY release. However, if H2O2 serves to release PLY, it appears that it may act from within the bacterial cell, as supplementation of exogenous H2O2, surprisingly, did not enhance PLY release, at least in the T4R strain. Also, while both spxB and ply are known to be differentially expressed in different biological niches during infection , ply was not found to be expressed greater in parental strains as compared to ∆spxB strains.
Our results indicate that the PLY release mechanism appears to be autolysis-independent, as mutants lacking the major autolytic cell wall amidase LytA were equally able to release PLY as parental strains. Furthermore, double mutants lacking both SpxB and LytA released equal PLY to strains lacking only SpxB. However, it is possible that additional autolytic factors including the murein hydrolase LytB, competence induced bacteriocin (CibAB), or choline binding protein D (CbpD) could play a role in spxB-dependent PLY release [38–40]. Results from exposure of the parental strain T4R to deoxycholate indicate that spxB expression may predispose the bacterial cells to autolysis. This indicates that H2O2 or some other SpxB-induced byproduct could weaken the bacterial cell membrane allowing for release of PLY from the intracellular space, possibly in the absence of cell death. However, loss of cell membrane integrity would likely free intracellular stores of LytA which could trigger autolytic effects not seen in our studies [41, 42]. An intriguing possibility is that PLY possesses characteristics that allow it to preferentially traverse the SpxB-perturbed membrane. We are currently investigating whether other cryptically secreted proteins may escape the cytosol via the SpxB-dependent mechanism used by PLY.
We have yet to determine is whether or not H2O2 produced by SpxB impacts pneumococcal activators or repressors, thereby indirectly affecting expression of genes that could impact PLY release. In Staphylococcus aureus, exposure to exogenous H2O2 enhanced expression of multiple oxidative stress response genes controlled by the ferric uptake regulator (Fur) homolog PerR . While pneumococcus doesn’t possess PerR, the iron uptake regulator RitR regulates expression of a number of genes which are impacted by both iron availability and oxidative stress . The MerR regulators of pneumococcus are another group of regulatory proteins that can be impacted by oxidative stress .
Since SpxB is an important metabolic enzyme for the organism during aerobic growth, our findings could link cytotoxic potential of strains to metabolic shifts that occur at different niches throughout the host during colonization or progression to invasive disease. This mechanism could constitute another reason for the attenuated virulence seen with spxB-negative mutants . However, it was recently demonstrated that increased PLY release does not necessarily translate to enhanced virulence . This underlines SpxB as an important virulence regulator, as our data indicate that SpxB expression contributes significantly to the release of PLY at early phases of growth, along with previous data indicating that it allows the organism to outcompete other common inhabitants of the nasopharynx . These findings could represent a novel method for protein secretion that extends beyond pneumococcus to other bacterial species.
Expression of SpxB was shown to contribute to PLY release in various S. pneumoniae strains. While a panel of clinical isolates demonstrated a correlation between H2O2 production and PLY release, catalase was able to prevent PLY release in a strain-dependent manner. This indicates endogenous/exogenous H2O2 may contribute in a strain-dependent fashion to SpxB-dependent PLY release. PLY release due to SpxB was not dependent upon cellular turnover based on plate counts and DNA release. Though SpxB-dependent PLY release was not dependent on the activity of the cell wall amidase LytA, deoxycholate-induced autolysis was greater in strains expressing SpxB, indicating possible weakening of the cell membrane when SpxB is expressed. These results identify a novel route of PLY release that may extend to secretion of other cytoplasmic proteins that lack signal sequences.
- H2O2 :
Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4(3):144–54.
O’Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374(9693):893–902.
Marcy M, Takata G, Chan LS, Shekelle P, Mason W, Wachsman L, Ernst R, Hay JW, Corley PM, Morphew T, et al. Management of acute otitis media. Evid Rep Technol Assess (Summ). 2000;15:1–4.
Le Polain de Waroux O, Flasche S, Prieto-Merino D, Edmunds WJ. Age-dependent prevalence of nasopharyngeal carriage of streptococcus pneumoniae before conjugate vaccine introduction: a prediction model based on a meta-analysis. PLoS One. 2014;9(1):e86136.
Berry AM, Lock RA, Thomas SM, Rajan DP, Hansman D, Paton JC. Cloning and nucleotide sequence of the Streptococcus pneumoniae hyaluronidase gene and purification of the enzyme from recombinant Escherichia coli. Infect Immun. 1994;62(3):1101–8.
Briles DE, Yother J, McDaniel LS. Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. Rev Infect Dis. 1988;10 Suppl 2:S372–4.
Camara M, Boulnois GJ, Andrew PW, Mitchell TJ. A neuraminidase from Streptococcus pneumoniae has the features of a surface protein. Infect Immun. 1994;62(9):3688–95.
Mitchell TJ, Dalziel CE. The biology of pneumolysin. Subcell Biochem. 2014;80:145–60.
Marriott HM, Jackson LE, Wilkinson TS, Simpson AJ, Mitchell TJ, Buttle DJ, Cross SS, Ince PG, Hellewell PG, Whyte MK, et al. Reactive oxygen species regulate neutrophil recruitment and survival in pneumococcal pneumonia. Am J Respir Crit Care Med. 2008;177(8):887–95.
Rogers PD, Thornton J, Barker KS, McDaniel DO, Sacks GS, Swiatlo E, McDaniel LS. Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by Streptococcus pneumoniae. Infect Immun. 2003;71(4):2087–94.
Walker JA, Allen RL, Falmagne P, Johnson MK, Boulnois GJ. Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae. Infect Immun. 1987;55(5):1184–9.
Price KE, Greene NG, Camilli A. Export requirements of pneumolysin in Streptococcus pneumoniae. J Bacteriol. 2012;194(14):3651–60.
Mitchell TJ, Alexander JE, Morgan PJ, Andrew PW. Molecular analysis of virulence factors of Streptococcus pneumoniae. Soc Appl Bacteriol Symp Ser. 1997;26:62S–71.
Balachandran P, Hollingshead SK, Paton JC, Briles DE. The autolytic enzyme LytA of Streptococcus pneumoniae is not responsible for releasing pneumolysin. J Bacteriol. 2001;183(10):3108–16.
Price KE, Camilli A. Pneumolysin localizes to the cell wall of Streptococcus pneumoniae. J Bacteriol. 2009;191(7):2163–8.
Greene NG, Narciso AR, Filipe SR, Camilli A. Peptidoglycan Branched Stem Peptides Contribute to Streptococcus pneumoniae Virulence by Inhibiting Pneumolysin Release. PLoS Pathog. 2015;11(6):e1004996.
Marriott HM, Mitchell TJ, Dockrell DH. Pneumolysin: a double-edged sword during the host-pathogen interaction. Curr Mol Med. 2008;8(6):497–509.
McLeod JW, Gordon J. Production of Hydrogen Peroxide by Bacteria. Biochem J. 1922;16(4):499–506.
Pericone CD, Park S, Imlay JA, Weiser JN. Factors contributing to hydrogen peroxide resistance in Streptococcus pneumoniae include pyruvate oxidase (SpxB) and avoidance of the toxic effects of the fenton reaction. J Bacteriol. 2003;185(23):6815–25.
Taniai H, Iida K, Seki M, Saito M, Shiota S, Nakayama H, Yoshida S. Concerted action of lactate oxidase and pyruvate oxidase in aerobic growth of Streptococcus pneumoniae: role of lactate as an energy source. J Bacteriol. 2008;190(10):3572–9.
Spellerberg B, Cundell DR, Sandros J, Pearce BJ, Idanpaan-Heikkila I, Rosenow C, Masure HR. Pyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae. Mol Microbiol. 1996;19(4):803–13.
Pericone CD, Overweg K, Hermans PW, Weiser JN. Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect Immun. 2000;68(7):3990–7.
Braun JS, Sublett JE, Freyer D, Mitchell TJ, Cleveland JL, Tuomanen EI, Weber JR. Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. J Clin Invest. 2002;109(1):19–27.
Rai P, Parrish M, Tay IJ, Li N, Ackerman S, He F, Kwang J, Chow VT, Engelward BP. Streptococcus pneumoniae secretes hydrogen peroxide leading to DNA damage and apoptosis in lung cells. Proc Natl Acad Sci U S A. 2015;112(26):E3421–30.
Rubins JB, Duane PG, Charboneau D, Janoff EN. Toxicity of pneumolysin to pulmonary endothelial cells in vitro. Infect Immun. 1992;60(5):1740–6.
Zysk G, Bejo L, Schneider-Wald BK, Nau R, Heinz H. Induction of necrosis and apoptosis of neutrophil granulocytes by Streptococcus pneumoniae. Clin Exp Immunol. 2000;122(1):61–6.
Regev-Yochay G, Trzcinski K, Thompson CM, Lipsitch M, Malley R. SpxB is a suicide gene of Streptococcus pneumoniae and confers a selective advantage in an in vivo competitive colonization model. J Bacteriol. 2007;189(18):6532–9.
Pesakhov S, Benisty R, Sikron N, Cohen Z, Gomelsky P, Khozin-Goldberg I, Dagan R, Porat N. Effect of hydrogen peroxide production and the Fenton reaction on membrane composition of Streptococcus pneumoniae. Biochim Biophys Acta. 2007;1768(3):590–7.
Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, Heidelberg J, DeBoy RT, Haft DH, Dodson RJ, et al. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science. 2001;293(5529):498–506.
Fernebro J, Andersson I, Sublett J, Morfeldt E, Novak R, Tuomanen E, Normark S, Normark BH. Capsular expression in Streptococcus pneumoniae negatively affects spontaneous and antibiotic-induced lysis and contributes to antibiotic tolerance. J Infect Dis. 2004;189(2):328–38.
Briles DE, Nahm M, Schroer K, Davie J, Baker P, Kearney J, Barletta R. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med. 1981;153(3):694–705.
Thornton JA. Splicing by Overlap Extension PCR to Obtain Hybrid DNA Products. Methods Mol Biol. 2016;1373:43–9.
Udaka S, Koukol J, Vennesland B. Lactic oxidase of Pneumococcus. J Bacteriol. 1959;78:714–25.
Ronda C, Garcia JL, Garcia E, Sanchez-Puelles JM, Lopez R. Biological role of the pneumococcal amidase. Cloning of the lytA gene in Streptococcus pneumoniae. Eur J Biochem. 1987;164(3):621–4.
Benton KA, Paton JC, Briles DE. Differences in virulence for mice among Streptococcus pneumoniae strains of capsular types 2, 3, 4, 5, and 6 are not attributable to differences in pneumolysin production. Infect Immun. 1997;65(4):1237–44.
Loose M, Hudel M, Zimmer KP, Garcia E, Hammerschmidt S, Lucas R, Chakraborty T, Pillich H. Pneumococcal hydrogen peroxide-induced stress signaling regulates inflammatory genes. J Infect Dis. 2015;211(2):306–16.
Orihuela CJ, Radin JN, Sublett JE, Gao G, Kaushal D, Tuomanen EI. Microarray analysis of pneumococcal gene expression during invasive disease. Infect Immun. 2004;72(10):5582–96.
Garcia P, Gonzalez MP, Garcia E, Lopez R, Garcia JL. LytB, a novel pneumococcal murein hydrolase essential for cell separation. Mol Microbiol. 1999;31(4):1275–81.
Kausmally L, Johnsborg O, Lunde M, Knutsen E, Havarstein LS. Choline-binding protein D (CbpD) in Streptococcus pneumoniae is essential for competence-induced cell lysis. J Bacteriol. 2005;187(13):4338–45.
Guiral S, Mitchell TJ, Martin B, Claverys JP. Competence-programmed predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: genetic requirements. Proc Natl Acad Sci U S A. 2005;102(24):8710–5.
Mellroth P, Sandalova T, Kikhney A, Vilaplana F, Hesek D, Lee M, Mobashery S, Normark S, Svergun D, Henriques-Normark B, et al. Structural and functional insights into peptidoglycan access for the lytic amidase LytA of Streptococcus pneumoniae. MBio. 2014;5(1):e01120–01113.
Mellroth P, Daniels R, Eberhardt A, Ronnlund D, Blom H, Widengren J, Normark S, Henriques-Normark B. LytA, major autolysin of Streptococcus pneumoniae, requires access to nascent peptidoglycan. J Biol Chem. 2012;287(14):11018–29.
Horsburgh MJ, Clements MO, Crossley H, Ingham E, Foster SJ. PerR controls oxidative stress resistance and iron storage proteins and is required for virulence in Staphylococcus aureus. Infect Immun. 2001;69(6):3744–54.
Ulijasz AT, Andes DR, Glasner JD, Weisblum B. Regulation of iron transport in Streptococcus pneumoniae by RitR, an orphan response regulator. J Bacteriol. 2004;186(23):8123–36.
Brown NL, Stoyanov JV, Kidd SP, Hobman JL. The MerR family of transcriptional regulators. FEMS Microbiol Rev. 2003;27(2–3):145–63.
We would like to thank Mary Marquart for providing rabbit polyclonal anti-PLY antibody.
JAT’s lab is supported by an Institutional Development Award (IDeA) from the NIGMS COBRE grant number (P20GM103646), the MSU Department of Biological Sciences, and the MSU Office of Research and Economic Development.
Availability of data and materials
All materials used or generated in this study, including genetically modified strains, will be made freely available to any scientist wishing to use them for non-commercial purposes.
JB participated in design and completion of all experiments in the study and drafted the manuscript. RD performed autolysis assays and western blots. KO and LB performed molecular genetic studies and generated knockout strains. JR, KS, JD, and LM made substantial contributions to the conception and design of experiments. JT designed and coordinated all studies and contributed to drafting the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
Deletion of spxB greatly reduces production of hydrogen peroxide. The amount of hydrogen peroxide in culture supernatants from wild type and mutant strains lacking SpxB (A. AW267; B. WU2; C. T4, D. T4R) was measured via a colorimetric peroxide assay. Asterisks indicate statistical significance (**** p < 0.00005, **p < 0.005) and ND indicates a peroxide concentration below the detectable limits of the assay. (TIF 534 kb)
Bacterial colony counts. Serial dilution plate counts were made at OD 0.5 of the indicated strains to determine if there was a difference in the bacterial counts when SpxB is removed, or when catalase is added. Each figure represents three independent experiments ± SD. (TIF 540 kb)
Bacterial colony counts. Serial dilution plate counts were made from cultures grown to OD600 0.5 prior to and 1 h post-exposure to various concentrations of H2O2. Results are shown as the average of 3 independent experiments ± SD. (TIF 481 kb)
About this article
Cite this article
Bryant, J.C., Dabbs, R.C., Oswalt, K.L. et al. Pyruvate oxidase of Streptococcus pneumoniae contributes to pneumolysin release. BMC Microbiol 16, 271 (2016). https://doi.org/10.1186/s12866-016-0881-6